CSWM
ROIV icon

Cassady Schiller Wealth Management’s Roivant Sciences ROIV Stock Holding History

Cassady Schiller Wealth Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$24 Buy
+2
New +$24 ﹤0.01% 1138

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Cassady Schiller Wealth Management's ROIV Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Roivant Sciences (ROIV) in Q4 2024: 2 shares worth $24. The stake represents ﹤0.01% of the portfolio and ranks #1138 among its holdings.

318 funds tracked by Wall St. Rank hold ROIV as of Q4 2024.

  • Cassady Schiller Wealth Management held 2 shares of Roivant Sciences worth $24 as of Q4 2024.
  • Roivant Sciences was a new Cassady Schiller Wealth Management position in Q4 2024.
  • Roivant Sciences made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #1138 holding.
  • 318 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.